MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-27-2026
Inogen Retained Earnings 2011-2026 | INGN
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Inogen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -176 M | -153 M | -117 M | -14.5 M | 69.3 M | 75.6 M | 81.4 M | 60.5 M | 8.64 M | -12.4 M | -45.1 M | -56.7 M | -62.6 M | -81 M | -75.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 81.4 M | -176 M | -33.2 M |
Quarterly Retained Earnings Inogen
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -168 M | -163 M | -159 M | -153 M | -143 M | -137 M | -132 M | -117 M | -90.4 M | -44.7 M | -34.8 M | -14.5 M | 42.1 M | - | 55.1 M | 69.3 M | 92.1 M | 80 M | 74.9 M | 75.6 M | 75.6 M | 75.6 M | 75.6 M | 81.4 M | 81.4 M | 81.4 M | 81.4 M | 60.5 M | 60.5 M | 60.5 M | 60.5 M | 8.64 M | 8.64 M | 8.64 M | 8.64 M | -12.4 M | -12.4 M | -12.4 M | -12.4 M | -45.1 M | -45.1 M | -45.1 M | -45.1 M | -56.7 M | -56.7 M | -56.7 M | -56.7 M | -62.6 M | -62.6 M | -62.6 M | -62.6 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 92.1 M | -168 M | -14.9 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
-1.42 B | $ 12.42 | -4.46 % | $ 1.86 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
2.41 B | $ 38.55 | 0.13 % | $ 5.74 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
-157 M | $ 8.31 | 1.4 % | $ 597 M |  Israel |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 9.61 | -0.62 % | $ 1.3 B | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
21.2 M | $ 24.26 | -0.12 % | $ 205 M | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 41.66 | -3.09 % | $ 1.29 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 4.19 | -1.41 % | $ 156 M |  France |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
AxoGen
AXGN
|
-307 M | $ 29.15 | -0.24 % | $ 1.34 B | USA |
 |
Apyx Medical Corporation
APYX
|
-54.4 M | $ 3.27 | -0.82 % | $ 113 M | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Second Sight Medical Products
EYES
|
-122 M | - | -0.97 % | $ 54.4 M | USA |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 18.59 | 0.3 % | $ 122 M | USA |
 |
Accuray Incorporated
ARAY
|
-519 M | $ 0.5 | -4.78 % | $ 51.4 M | USA |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
Cytosorbents Corporation
CTSO
|
-304 M | $ 0.81 | 1.91 % | $ 44.1 M | USA |
 |
Align Technology
ALGN
|
2.48 B | $ 175.78 | -3.51 % | $ 13.2 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 3.7 | -8.31 % | $ 783 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
49.8 B | $ 110.91 | -1.94 % | $ 193 B | USA |
 |
InMode Ltd.
INMD
|
969 M | $ 13.49 | -0.55 % | $ 872 M | Israel |
 |
BioSig Technologies
BSGM
|
-255 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
5.57 B | $ 72.61 | 0.55 % | $ 107 B | USA |
 |
IRIDEX Corporation
IRIX
|
-79 M | $ 1.4 | -0.71 % | $ 22.6 M | USA |
 |
IRadimed Corporation
IRMD
|
56.8 M | $ 100.27 | -4.6 % | $ 1.27 B | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 2.26 | -2.16 % | $ 1.37 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 17.55 | -5.03 % | $ 412 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 83.7 | -1.78 % | $ 48.9 B | USA |
 |
Pulmonx Corporation
LUNG
|
-468 M | $ 1.61 | 12.07 % | $ 63 M | USA |
 |
LivaNova PLC
LIVN
|
-1.15 B | $ 64.29 | -1.49 % | $ 3.51 B |  Britain |